![Sean Scanlan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Scanlan
Corporate Officer/Principal chez
TREACE MEDICAL CONCEPTS, INC.
Fortune : 694 630 $ au 31/05/2026
Profil
Sean F.
Scanlan is Chief Innovation Officer at Treace Medical Concepts, Inc. since 2023.
Formerly, Dr. Scanlan was Principal at Smith & Nephew plc from 2011 to 2014.
Education includes undergraduate studies at the University of Florida and graduate and doctorate degrees from Stanford University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/03/2026 | 200 760 ( 0,31% ) | 694 630 $ | 31/05/2026 |
Postes actifs de Sean Scanlan
| Sociétés | Poste | Début |
|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. | Corporate Officer/Principal | 01/01/2023 |
Anciens postes connus de Sean Scanlan
| Sociétés | Poste | Fin |
|---|---|---|
| SMITH & NEPHEW PLC | Corporate Officer/Principal | 01/04/2014 |
Formation de Sean Scanlan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Smith & Nephew plc
 Smith & Nephew plc Medical SpecialtiesHealth Technology Develops, manufactures and markets medical technology devices | Health Technology |
Treace Medical Concepts, Inc.
 Treace Medical Concepts, Inc. Medical SpecialtiesHealth Technology Manufactures and sells orthopedic medical devices | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
